Erratum (DOI:10.1016/j.jcrs.2006.08.043);Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery

Journal of Cataract and Refractive Surgery

Volumn 33, Issue 1, 2007, Pages 53-58

  Lane, Stephen S ^a   Modi, Satish S ^a   Lehmann, Robert P ^a   Holland, Edward J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DRUG VEHICLE; MOXIFLOXACIN; NEPAFENAC; PLACEBO;

ADULT; AGED; ANALGESIA; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EYE INFLAMMATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUSPENSION;

EID: 33845770182     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2007.03.003     Document Type: Erratum

References (19)

1. Heier J., Cheetham J.K., DeGryse R., et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 127 (1999) 253-259
2. Flach A.J., Dolan B.J., Donahue M.E., et al. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 105 (1998) 1775-1779
3. Roberts C.W. Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. Ophthalmology 103 (1996) 636-639
4. Simone J.N., and Whitacre M.M. Effects of anti-inflammatory drugs following cataract extraction. Curr Opin Ophthalmol 12 (2001) 63-67
5. Solomon K.D., Vroman D.T., Barker D., and Gehlken J. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction; prospective randomized double-masked study. J Cataract Refract Surg 27 (2001) 1232-1237
6. Brennan K.M., Brown R.M., and Roberts C.W. A comparison of topical non-steroidal anti-inflammatory drugs to steroids for control of post cataract inflammation. Insight J Am Soc Ophthalmic Reg Nurses 18 1 (1993) 8-9, 11
7. Rowen S. Preoperative and postoperative medications used for cataract surgery. Curr Opin Ophthalmol 10 (1999) 29-35
8. El-Harazi S.M., Ruiz R.S., Feldman R.M., et al. Efficacy of preoperative versus postoperative ketorolac tromethamine 0.5% in reducing inflammation after cataract surgery. J Cataract Refract Surg 26 (2000) 1626-1630
9. Flach A.J. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin 42 1 (2002) 1-11
10. Flach A.J., Lavelle C.J., Olander K.W., et al. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology 95 (1988) 1279-1284
11. Solomon K.D., Cheetham J.K., DeGryse R., et al. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108 (2001) 331-337
12. Flach A.J., Jaffe N.S., and Akers W.A. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-masked parallel comparison with dexamethasone. Ann Ophthalmol 21 (1989) 407-411
13. Holzer M.P., Solomon K.D., Sandoval H.P., and Vroman D.T. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification; prospective randomized double-masked study. J Cataract Refract Surg 28 (2002) 93-99
14. Roberts C.W., and Brennan K.M. A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol 113 (1995) 725-727
15. O'Brien T.P. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 21 (2005) 1131-1137 erratum, 1431-1432
16. Phero J.C., Becker D.E., and Dionne R.A. Contemporary trends in acute pain management. Curr Opin Otolaryngol Head Neck Surg 12 (2004) 209-216
17. Gamache D.A., Graff G., Brady M.T., et al. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation 24 (2000) 357-370
18. Ke T.-L., Graff G., Spellman J.M., and Yanni J.M. Nepafenac a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Inflammation 24 (2000) 371-384
19. Kapin M.A., Yanni J.M., Brady M.T., et al. Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. Inflammation 27 (2003) 281-291